Simplified lansoprazole suspension - A liquid formulation of lansoprazole - Effectively suppresses intragastric acidity when administered through a gastrostomy

American Journal of Gastroenterology

Volumn 94, Issue 7, 1999, Pages 1813-1817

  Sharma, Virender K ^a,b   Vasudeva, Rajeev ^b   Howden, Colin W ^b  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; GASTROSTOMY; HUMAN; MALE; PATIENT MONITORING; PH MEASUREMENT; PRIORITY JOURNAL; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTROSTOMY; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; SUSPENSIONS;

EID: 0033013797     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00266-X     Document Type: Article

References (15)

1. Barradell L.V., Fauld D., McTavish D. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorder. Drugs. 44:1992;22-50.
2. Hawkey C.J., Long R.G., Bradhan K.D., et al. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut. 34:1993;1458-1462.
3. Hotz J., Kleiner R., Grymbowski T., et al. Lansoprazole versus famotidine Efficacy and tolerance in the acute management of duodenal ulcer . Aliment Pharmacol Ther. 6:1992;87-95.
4. Robinson M., Sahba B., Avner D., et al. A comparison of lansoprazole and ranitidine in the treatment of erosive esophagitis. Aliment Pharmacol Ther. 9:1995;25-31.
5. Petite J.-P., Slama J.-L., Licht L., et al. Lansoprazole and omeprazole in the treatment of duodenal ulcer A multicenteric double-blinded comparitive trial . Gastroenterol Clin Biol. 17:1993;334-340.
6. Hatlebakk J.G., Berstad A., Carling L., et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicenter trial. Scand J Gastroenterol. 28:1993;224-228.
7. Sharma V.K., Heinzelmann E.J., Steinberg E.N., et al. Nonencapsulated, intact omeprazole granules effectively suppress intragastric acidity when administered via a gastrostomy. Am J Gastroenterol. 92:1997;848-851.
8. Sharma V.K., Ugheoke E.A., Vasudeva R., et al. A study of the pharmacodynamics of lansoprazole administered via gastrostomy as intact, nonencapsulated granules. Aliment Pharmacol Ther. 12:1998;1171-1174.
9. Chun A.H., Eason C.J., Shi H.H., et al. Lansoprazole An alternative method of administration of a capsule dosage formulation . Clin Ther. 17:1995;441-447.
10. Chun A.H., Shi H.H., Achari R., et al. Lansoprazole Administration of the contents of a capsule dosage formulation through a nasogastric tube . Clin Ther. 18:1996;833-842.
11. Lochart S.P., Baxter G. A lansoprazole suspension formulation as an alternative to capsules for oral administration. Digestion. 59:1998;226. (abstract).
12. Sharma V.K., Vasudeva R., Howden C.W. Effect on 24-hour intragastric acidity of simplified omeprazole solution (SOS) administered via gastrostomy. Am J Gastroenterol. 92:1997;1625. (abstract).
13. Tolman K.G., Sanders S.W., Buchi K.N., et al. The effects of oral doses of lansoprazole and omeprazole on gastric pH. J Clin Gastroenterol. 24:1997;65-70.
14. Burget D.W., Chiverton S.G., Hunt R.H. Is there an optimal degree of acid suppression for healing of duodenal ulcer? A model of the relationship between ulcer healing and acid suppression. Gastroenterol. 99:1990;345-351.
15. Bell N.J.V., Howden C.W., Burget D., et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion. 51:(suppl 1):1992;59-67.